A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S. Heitmann(Universitätsklinikum Tübingen), Juliane S. Walz(University Children's Hospital Tübingen)
Cited by 273
Related Papers
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
|Nature Communications|2022|73
Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
|Cancer Discovery|2021|47
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
|Blood Cancer Journal|2020|21
Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia
|Journal of Leukocyte Biology|2018|12